Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate the effect and adverse side effects of membrane-inhibiting formula plus oral progestins as fertility-preserving treatment in patients with early-stage en...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Women's Hospital School Of Medicine Zhejiang University
NCT05903131 · Endometrial Hyperplasia, Grade 1 Endometrial Cancer
NCT03538665 · Endometrial Cancer, Endometrial Cancer Precursors, and more
NCT05316493 · Atypical Endometrial Hyperplasia, Fertility Issues, and more
NCT05316935 · Endometrial Neoplasms, Atypical Endometrial Hyperplasia, and more
NCT07077876 · Endometrial Adenocarcinoma, Endometrial Hyperplasia, and more
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions